Published in Lancet on January 21, 1978
Metabolite profiling identifies markers of uremia. J Am Soc Nephrol (2010) 1.63
Carnitine metabolism and inborn errors. J Inherit Metab Dis (1984) 1.30
Plasma and muscle free carnitine deficiency due to renal Fanconi syndrome. J Clin Invest (1985) 0.99
L-Carnitine. Arch Dis Child (1996) 0.89
Creatine, L-carnitine, and ω3 polyunsaturated fatty acid supplementation from healthy to diseased skeletal muscle. Biomed Res Int (2014) 0.81
Proton magnetic resonance spectroscopy of skeletal muscle: a comparison of two quantitation techniques. J Magn Reson (2014) 0.77
Differential effects of oral and intravenous l-carnitine on serum lipids: is the microbiota the answer? Clin Kidney J (2014) 0.76
Long-term L-carnitine administration reduces erythropoietin resistance in chronic hemodialysis patients with thalassemia minor. Drug Target Insights (2007) 0.76
Carnitine supplementation improves apolipoprotein B levels in pediatric peritoneal dialysis patients. Pediatr Nephrol (2003) 0.75
The cytotoxic activity of Shigella toxin. Evidence for catalytic inactivation of the 60 S ribosomal subunit. J Biol Chem (1981) 3.13
Isolation and characterization of Shigella shigae cytotoxin. J Biol Chem (1980) 2.78
Subunit structure of Shigella cytotoxin. J Biol Chem (1981) 2.59
Another case of imprinting defect in a girl with Angelman syndrome who was conceived by intracytoplasmic semen injection. Am J Hum Genet (2003) 1.86
Interaction of Shigella shigae cytotoxin with receptors on sensitive and insensitive cells. J Recept Res (1980) 1.76
Entry of lethal doses of abrin, ricin and modeccin into the cytosol of HeLa cells. Exp Cell Res (1980) 1.69
Animal toxicity of Shigella dysenteriae cytotoxin: evidence that the neurotoxic, enterotoxic, and cytotoxic activities are due to one toxin. J Immunol (1983) 1.60
Consequences of late referral of patients with end-stage renal disease. J Intern Med (2001) 1.32
Quantitative studies of the metabolism of chylomicron triglycerides and cholesterol by liver and extrahepatic tissues of sheep and dogs. J Clin Invest (1971) 1.30
Propionylcarnitine. Physiological variations in vivo. Biochim Biophys Acta (1968) 1.25
Mapping of the locus for cholestasis-lymphedema syndrome (Aagenaes syndrome) to a 6.6-cM interval on chromosome 15q. Am J Hum Genet (2000) 1.09
Entry of Shigella dysenteriae toxin into HeLa cells. Infect Immun (1983) 1.06
Tissue levels of activated fatty acids (acylcarnitines) and the regulation of fatty acid metabo.ism. Biochim Biophys Acta (1967) 1.02
CT characterization of developmental variations of the paranasal sinuses in cystic fibrosis. Acta Radiol (2001) 0.95
Fatal outcome of low-dose methotrexate therapy in rheumatoid arthritis. Clin Rheumatol (1993) 0.95
Seven novel mutations and four exon deletions in a collection of Norwegian patients with SPG4 hereditary spastic paraplegia. Eur J Neurol (2007) 0.94
Properties and action mechanism of the toxic lectin modeccin: interaction with cell lines resistant to modeccin, abrin, and ricin. J Supramol Struct (1978) 0.92
Non-random X chromosome inactivation in an affected twin in a monozygotic twin pair discordant for Wiedemann-Beckwith syndrome. Am J Med Genet (1995) 0.90
Carnitine uptake into human heart cells in culture. Biochim Biophys Acta (1977) 0.89
Pharmacokinetics and protein binding of prednisolone after oral and intravenous administration. Eur J Clin Pharmacol (1983) 0.88
Physiological fatty liver and hyperlipemia in the fetal guinea pig: chemical and ultrastructural characterization. J Lipid Res (1972) 0.88
Goodpasture's syndrome. A report of seven patients including long-term follow-up of three who received a kidney transplant. Am J Med (1980) 0.86
Proposal of a CT scoring system of the paranasal sinuses in diagnosing cystic fibrosis. Eur Radiol (2003) 0.85
Specificity and characteristics of the carnitine transport in human heart cells (CCL 27) in culture. Biochim Biophys Acta (1977) 0.85
Inheritance of skewed X chromosome inactivation in a large family with an X-linked recessive deafness syndrome. Am J Med Genet (1996) 0.84
Dialysis death and increased free fatty acids. Lancet (1978) 0.84
Diabetic eye complications in a medium sized municipality in southwest Norway. Acta Ophthalmol Scand (1996) 0.83
Dialysis fistulas and cardiac failure. Acta Med Scand (1978) 0.83
Genesis of fatty liver and hyperlipemia in the fetal guinea pig. J Lipid Res (1975) 0.82
Pharmacokinetics and protein binding of prednisolone in patients with nephrotic syndrome and patients undergoing hemodialysis. Kidney Int (1983) 0.81
The conversion of valine to propionylcarnitine in isolated rat liver mitochondria. Biochim Biophys Acta (1970) 0.80
First referral of diabetic patients to a nephrologist. Diabet Med (2003) 0.79
Hypoplasia of the sphenoid sinuses as a diagnostic tool in cystic fibrosis. Acta Radiol (1999) 0.78
Altered prednisolone pharmacokinetics in patients treated with rifampicin. Acta Med Scand (1983) 0.77
Prednisolone pharmacokinetics in cushingoid and non-cushingoid kidney transplant patients. Kidney Int (1985) 0.77
Nutrition problems among home-living elderly people may lead to disease and hospitalization. Nutr Rev (1996) 0.77
Changes in prednisolone pharmacokinetics and protein binding during treatment with rifampicin. Proc Eur Dial Transplant Assoc (1983) 0.77
394delTT: a Nordic cystic fibrosis mutation. Hum Genet (1994) 0.76
Conversion of butyrobetaine to carnitine in the rat in vivo. Biochim Biophys Acta (1974) 0.76
Androgen-dependent accumulation of carnitine by rat epididymis after injection of [3H]butyrobetaine in vivo. Mol Cell Endocrinol (1975) 0.76
Targets for glycated haemoglobin. Targets set reference points for clinic comparisons. BMJ (1995) 0.75
[Pregnant diabetics. A retrospective study of pregnancy and labor in women with type 1 diabetes in Sør-Rogaland 1982-90]. Tidsskr Nor Laegeforen (1992) 0.75
Prednisolone pharmacokinetics and protein-binding in patients with portosystemic shunt. Scand J Gastroenterol (1983) 0.75
Prednisolone in renal transplantation: a comparison between two dosage regimes. Scand J Urol Nephrol Suppl (1981) 0.75
[Letter: Treatment in hypercholestermia]. Tidsskr Nor Laegeforen (1976) 0.75
The formation of propionylcarnitine in isolated rat liver mitochondria. Biochim Biophys Acta (1968) 0.75
[Hemolytic-uremic syndrome caused by verotoxin-producing Escherichia coli intestinal infection]. Tidsskr Nor Laegeforen (1994) 0.75
[Genotyping of apolipoprotein E]. Tidsskr Nor Laegeforen (1993) 0.75
Reduced thiamine phosphate, but not thiamine diphosphate, in erythrocytes in elderly patients with congestive heart failure treated with furosemide. J Intern Med (2000) 0.75
Blood pressure and pulse response to insulin-induced hypoglycemia during non-selective and selective beta-blockade. Acta Med Scand Suppl (1981) 0.75
[Neuroleptic malignant syndrome]. Tidsskr Nor Laegeforen (1989) 0.75
[Disturbances of calcium/phosphorus metabolism in chronic renal disease]. Tidsskr Nor Laegeforen (1974) 0.75
Clinical radionuclide-imaging of enlarged parathyroids with 131-I-toluidine blue. Acta Chir Scand (1974) 0.75
Immunosuppressive treatment policies. A) Glucocorticoids: absorption of prednisolone. I. The effect of fasting, food, and food combined with antacids. Scand J Urol Nephrol Suppl (1981) 0.75
The influence of uremia on pharmacokinetics and protein binding of prednisolone. Acta Med Scand (1983) 0.75
[Androcine (cyproterone acetate)--a drug with antiandrogenic effect]. Tidsskr Nor Laegeforen (1975) 0.75
Transsphenoidal subtotal hypophysectomy in the treatment of acromegaly. Acta Endocrinol (Copenh) (1974) 0.75
[Occurence of complications and/or malpractice after diagnosis and treatment in hospital]. Tidsskr Nor Laegeforen (1977) 0.75
Prognostic value of renal vein renin determination in suspected renovascular hypertension. Acta Med Scand (1982) 0.75
[Prevalence of diabetes in a 5-year material of amputations in Sør-Rogaland]. Tidsskr Nor Laegeforen (1992) 0.75
Bioavailability of prednisolone in patients with intestinal malabsorption: the importance of measuring serum protein-binding. Scand J Gastroenterol (1983) 0.75
Bromocriptine treatment in acromegaly: clinical and biochemical effects. Acta Endocrinol (Copenh) (1977) 0.75
Different prednisolone pharmacokinetics in Cushingoid and non-Cushingoid kidney transplant patients. Proc Eur Dial Transplant Assoc (1983) 0.75
Propionylcarnitine in animal tissue. Biochim Biophys Acta (1968) 0.75
[Use of information technology in quality development of diabetic care]. Tidsskr Nor Laegeforen (2000) 0.75
[Acromegaly. A review, especially of the treatment]. Tidsskr Nor Laegeforen (1976) 0.75